O Csuka Selected Research

TT2-32

9/2008	Continuous administration of the somatostatin structural derivative /TT-232/ by subcutaneously implanted osmotic pump improves the efficacy and potency of antitumor therapy in different mouse and human tumor models.
7/2006	A comparison of the tumor growth inhibitory effect of intermittent and continuous administration of the somatostatin structural derivative TT-232 in various human tumor models.
1/2005	Growth inhibitory effect of the somatostatin structural derivative (TT-232) on leukemia models.
9/2003	The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

O Csuka Research Topics

Disease

9	Neoplasms (Cancer) 09/2019 - 01/2000
3	Breast Neoplasms (Breast Cancer) 07/2006 - 09/2003
2	Melanoma (Melanoma, Malignant) 09/2008 - 09/2003
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2006 - 01/2001
2	Leukemia 01/2005 - 09/2003
2	Carcinoma (Carcinomatosis) 09/2003 - 01/2000
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2001 - 01/2001
2	Neoplasm Metastasis (Metastasis) 01/2001 - 01/2000
1	Microsatellite Instability 11/2014
1	Lymphoid Leukemia 09/2008
1	Sarcoma (Soft Tissue Sarcoma) 09/2008
1	Lymphoma (Lymphomas) 03/2005
1	Oropharyngeal Neoplasms 01/2001
1	Residual Neoplasm 01/2001
1	Colonic Neoplasms (Colon Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2008 - 09/2003
4	TT2-32IBA 09/2008 - 09/2003
3	Antineoplastic Agents (Antineoplastics)IBA 09/2008 - 09/2003
2	Proteins (Proteins, Gene)FDA Link 03/2005 - 01/2000
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2001 - 01/2001
2	Biological ProductsIBA 01/2001 - 01/2000
1	RNA (Ribonucleic Acid)IBA 09/2019
1	MicroRNAs (MicroRNA)IBA 09/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2014
1	formononetinIBA 03/2005
1	FlavonoidsIBA 03/2005
1	Pharmaceutical PreparationsIBA 03/2005
1	Epirubicin (Ellence)FDA LinkGeneric 03/2005
1	amorphigeninIBA 03/2005
1	chrysinIBA 03/2005
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2003
1	Radiation-Sensitizing AgentsIBA 01/2001
1	Genetic Markers (Genetic Marker)IBA 01/2001
1	ParaffinIBA 01/2000
1	Proto-Oncogene Proteins c-metIBA 01/2000
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2000

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 09/2008 - 01/2001
2	Therapeutics 09/2008 - 01/2001
2	Radiotherapy 01/2001 - 01/2001
1	Ligation 11/2014